April 6, 2020
HRSA’s Office of Pharmacy Affairs (OPA) has posted guidance for 340B covered entities during the COVID-19 pandemic. The guidance can be accessed on the HRSA OPA website at https://www.hrsa.gov/opa/COVID-19-resources. Some of the [...]
February 7, 2020
FTLF Partners Michael Glomb and Jason Reddish will participate in the 2020 340B Coalition Winter Conference next week in San Diego, CA. During the three-day conference, FTLF will present at the following sessions: Tuesday, [...]
January 9, 2020
CLIENT ALERT: CMS Issues Info Bulletin for State Medicaid Agencies to Avoid 340B Duplicate Discounts
On January 8, 2020, CMS’ Center for Medicaid and CHIP Services (CMCS) issued an Informational Bulletin (“Bulletin”) sharing best practices with state Medicaid agencies for the prevention of 340B program Medicaid duplicate [...]
April 8, 2019
FTLF Partner Michael B. Glomb, a senior member of FTLF’s Health Care Practice Group, will make a presentation on Using 340B Drugs Across the Continuum of Care: How to Provide Quality Service and [...]
April 8, 2019
Covered entities in the 340B Discount Drug Program now can verify that drug manufacturers are charging them no more than the “ceiling price” for a given drug. On Monday, April 1, the [...]
February 13, 2019
On January 31, 2019, the Trump Administration announced proposed changes to safe harbor protections under the Anti-Kickback Statute (AKS), which could impact the pharmaceutical market and indirectly the 340B Discount Drug Program. [...]
January 11, 2019
On Monday, January 7, 2019, California’s newly inaugurated Governor, Gavin Newsom, issued an Executive Order (EO) directing state agencies, including Medi-Cal, to jointly negotiate prescription drug pricing and as a single-purchaser system. [...]
December 28, 2018
On December 27, hospitals participating in the federal 340B drug discount program that are paid under the Medicare Outpatient Prospective Payment System (OPPS) scored a major victory in their fight against severe [...]
November 29, 2018
New guidance clarifies ability of RWHAP providers to partner with city, county, and local jails for HIV/AIDS care and medication and carries 340B program implications. As 2018 comes to a close, we [...]
August 7, 2018
On August 1, the Energy & Commerce Committee (E&C Committee) of the House of Representatives sent letters to nine contract pharmacies that participate in the 340B Drug Pricing Program (340B Program), requesting [...]